Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.

Inoue T, Hyodo T, Murakami T, Takayama Y, Nishie A, Higaki A, Korenaga K, Sakamoto A, Osaki Y, Aikata H, Chayama K, Suda T, Takano T, Miyoshi K, Koda M, Numata K, Tanaka H, Iijima H, Ochi H, Hirooka M, Imai Y, Kudo M.

Dig Dis. 2013;31(5-6):472-9. doi: 10.1159/000355248. Epub 2013 Nov 21.

2.

Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.

Toyoda H, Kumada T, Tada T, Sone Y, Maeda A, Kaneoka Y.

Hepatol Int. 2015 Jan;9(1):84-92. doi: 10.1007/s12072-014-9553-5. Epub 2014 Jul 23.

PMID:
25788383
3.

Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Matsuda M, Tsuda T, Yoshioka S, Murata S, Tanaka H, Hirooka M, Hiasa Y, Mochizuki T.

Jpn J Radiol. 2014 Jul;32(7):405-13. doi: 10.1007/s11604-014-0323-z. Epub 2014 May 24.

PMID:
24854900
4.

Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.

Toyoda H, Kumada T, Tada T, Niinomi T, Ito T, Sone Y, Kaneoka Y, Maeda A.

J Hepatol. 2013 Jun;58(6):1174-80. doi: 10.1016/j.jhep.2013.01.030. Epub 2013 Jan 29.

PMID:
23376360
5.

Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.

Inoue T, Hyodo T, Korenaga K, Murakami T, Imai Y, Higaki A, Suda T, Takano T, Miyoshi K, Koda M, Tanaka H, Iijima H, Ochi H, Hirooka M, Numata K, Kudo M.

J Gastroenterol. 2016 Feb;51(2):144-52. doi: 10.1007/s00535-015-1094-8. Epub 2015 Sep 15.

PMID:
26373860
6.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
7.

Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.

Ichikawa S, Ichikawa T, Motosugi U, Sano K, Morisaka H, Enomoto N, Matsuda M, Fujii H, Araki T.

J Magn Reson Imaging. 2014 Feb;39(2):293-7. doi: 10.1002/jmri.24164. Epub 2013 Apr 30.

PMID:
23633285
8.
9.
10.

Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease.

Takechi M, Tsuda T, Yoshioka S, Murata S, Tanaka H, Hirooka M, Mochizuki T.

Jpn J Radiol. 2012 Nov;30(9):743-51. doi: 10.1007/s11604-012-0120-5. Epub 2012 Sep 22.

PMID:
23001373
11.

Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?

Tamada T, Ito K, Yamamoto A, Yasokawa K, Higaki A, Kanki A, Sato T, Tanimoto D, Higashi H.

J Magn Reson Imaging. 2013 May;37(5):1093-9. doi: 10.1002/jmri.23903. Epub 2012 Nov 12.

PMID:
23148032
12.

Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A.

Eur J Radiol. 2012 Dec;81(12):3839-45. doi: 10.1016/j.ejrad.2012.06.027. Epub 2012 Aug 10.

PMID:
22884705
13.

Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.

Hyodo T, Murakami T, Imai Y, Okada M, Hori M, Kagawa Y, Kogita S, Kumano S, Kudo M, Mochizuki T.

Radiology. 2013 Feb;266(2):480-90. doi: 10.1148/radiol.12112677.

PMID:
23362095
14.

Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.

Di Pietropaolo M, Briani C, Federici GF, Marignani M, Begini P, Delle Fave G, Iannicelli E.

Clin Imaging. 2015 May-Jun;39(3):468-75. doi: 10.1016/j.clinimag.2014.12.020. Epub 2015 Jan 7.

PMID:
25748089
15.

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kawai K, Kozaka K.

J Comput Assist Tomogr. 2011 Mar-Apr;35(2):181-6. doi: 10.1097/RCT.0b013e3182026f3b.

PMID:
21412087
16.

High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results.

Higaki A, Ito K, Tamada T, Teruki S, Yamamoto A, Higashi H, Kanki A, Sato T, Noda Y.

J Magn Reson Imaging. 2013 Jun;37(6):1377-83. doi: 10.1002/jmri.23933. Epub 2012 Nov 21.

PMID:
23172841
17.

Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis.

Higaki A, Ito K, Tamada T, Sone T, Kanki A, Noda Y, Yasokawa K, Yamamoto A.

Eur Radiol. 2014 Oct;24(10):2476-81. doi: 10.1007/s00330-014-3293-8. Epub 2014 Jul 17.

PMID:
25030460
18.
19.

Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A.

Eur J Radiol. 2012 Nov;81(11):3002-9. doi: 10.1016/j.ejrad.2012.03.029. Epub 2012 Jun 29.

PMID:
22748558
20.

Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.

Nishie A, Asayama Y, Ishigami K, Kakihara D, Nakayama T, Ushijima Y, Takayama Y, Shirabe K, Fujita N, Kubo Y, Hirakawa M, Honda H.

J Gastroenterol Hepatol. 2014 Mar;29(3):561-7. doi: 10.1111/jgh.12423.

PMID:
24219648

Supplemental Content

Support Center